$NKTR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEKTAR THERAPEUTICS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NEKTAR THERAPEUTICS. Get notifications about new insider transactions in NEKTAR THERAPEUTICS for free.
Page: < prev 1 2 3 4 5 6 ... 12 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 20 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Sell | S | 17.97 | 8,863 | 159,268 | 219,009 | 227.9 K to 219 K (-3.89 %) |
Nov 15 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Option Exercise | M | 7.21 | 25,000 | 180,250 | 0 | |
Nov 15 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Sell | S | 19.79 | 25,000 | 494,750 | 227,872 | 252.9 K to 227.9 K (-9.89 %) |
Nov 15 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Buy | M | 7.21 | 25,000 | 180,250 | 252,872 | 227.9 K to 252.9 K (+10.97 %) |
Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 7.21 | 33,333 | 240,331 | 0 | |
Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 7.21 | 33,334 | 240,338 | 33,333 | |
Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 7.21 | 33,333 | 240,331 | 66,667 | |
Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 17.68 | 33,333 | 589,327 | 312,775 | 346.1 K to 312.8 K (-9.63 %) |
Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 7.21 | 33,333 | 240,331 | 346,108 | 312.8 K to 346.1 K (+10.66 %) |
Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 17.48 | 33,334 | 582,678 | 312,775 | 346.1 K to 312.8 K (-9.63 %) |
Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 7.21 | 33,334 | 240,338 | 346,109 | 312.8 K to 346.1 K (+10.66 %) |
Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 17.17 | 24,500 | 420,665 | 312,775 | 337.3 K to 312.8 K (-7.26 %) |
Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 16.35 | 8,833 | 144,420 | 337,275 | 346.1 K to 337.3 K (-2.55 %) |
Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 7.21 | 33,333 | 240,331 | 346,108 | 312.8 K to 346.1 K (+10.66 %) |
Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Option Exercise | M | 7.21 | 25,000 | 180,250 | 25,000 | |
Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Sell | S | 15.83 | 25,000 | 395,750 | 227,872 | 252.9 K to 227.9 K (-9.89 %) |
Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Buy | M | 7.21 | 25,000 | 180,250 | 252,872 | 227.9 K to 252.9 K (+10.97 %) |
Oct 02 2019 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Sell | S | 17.84 | 3,000 | 53,520 | 26,700 | 29.7 K to 26.7 K (-10.10 %) |
Oct 02 2019 | NKTR | NEKTAR THERAPEUTIC ... | Zalevsky Jonathan | Chief R&D Officer | Option Exercise | A | 18.43 | 150,000 | 2,764,500 | 150,000 | |
Oct 02 2019 | NKTR | NEKTAR THERAPEUTIC ... | Zalevsky Jonathan | Chief R&D Officer | Grant | A | 0.00 | 75,000 | 0 | 295,657 | 220.7 K to 295.7 K (+33.99 %) |
Oct 02 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Option Exercise | A | 18.43 | 150,000 | 2,764,500 | 150,000 | |
Oct 02 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Grant | A | 0.00 | 75,000 | 0 | 227,872 | 152.9 K to 227.9 K (+49.06 %) |
Oct 01 2019 | NKTR | NEKTAR THERAPEUTIC ... | Ajer Jeffrey Robert | Director | Sell | S | 18.06 | 2,375 | 42,893 | 22,375 | 24.8 K to 22.4 K (-9.60 %) |
Oct 01 2019 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Sell | S | 17.99 | 4,000 | 71,960 | 276,973 | 281 K to 277 K (-1.42 %) |
Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | EASTHAM KARIN | Director | Option Exercise | A | 18.80 | 13,000 | 244,400 | 13,000 | |
Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | EASTHAM KARIN | Director | Grant | A | 0.00 | 6,500 | 0 | 15,000 | 8.5 K to 15 K (+76.47 %) |
Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 18.80 | 13,000 | 244,400 | 13,000 | |
Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Grant | A | 0.00 | 6,500 | 0 | 188,250 | 181.8 K to 188.3 K (+3.58 %) |
Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Option Exercise | A | 18.80 | 13,000 | 244,400 | 13,000 | |
Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Grant | A | 0.00 | 6,500 | 0 | 29,700 | 23.2 K to 29.7 K (+28.02 %) |
Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | A | 18.80 | 13,000 | 244,400 | 13,000 | |
Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Grant | A | 0.00 | 6,500 | 0 | 151,583 | 145.1 K to 151.6 K (+4.48 %) |
Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | A | 18.80 | 13,000 | 244,400 | 13,000 | |
Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Grant | A | 0.00 | 6,500 | 0 | 280,973 | 274.5 K to 281 K (+2.37 %) |
Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | Ajer Jeffrey Robert | Director | Option Exercise | A | 18.80 | 13,000 | 244,400 | 13,000 | |
Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | Ajer Jeffrey Robert | Director | Grant | A | 0.00 | 6,500 | 0 | 24,750 | 18.3 K to 24.8 K (+35.62 %) |
Sep 24 2019 | NKTR | NEKTAR THERAPEUTIC ... | Ajer Jeffrey Robert | Director | Sell | S | 20.24 | 2,250 | 45,540 | 18,250 | 20.5 K to 18.3 K (-10.98 %) |
Sep 18 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 7.21 | 25,000 | 180,250 | 50,000 | |
Sep 18 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 20.52 | 25,000 | 513,000 | 152,872 | 177.9 K to 152.9 K (-14.06 %) |
Sep 18 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 7.21 | 25,000 | 180,250 | 177,872 | 152.9 K to 177.9 K (+16.35 %) |
Sep 09 2019 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Buy | P | 17.28 | 15,000 | 259,200 | 107,668 | 92.7 K to 107.7 K (+16.19 %) |
Aug 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 16.31 | 30,000 | 489,300 | 57,500 | |
Aug 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 16.31 | 30,000 | 489,300 | 152,872 | 122.9 K to 152.9 K (+24.42 %) |
Aug 26 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 16.31 | 30,000 | 489,300 | 195,000 | |
Aug 26 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 16.31 | 30,000 | 489,300 | 312,775 | 282.8 K to 312.8 K (+10.61 %) |
Aug 19 2019 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 18.15 | 1,809 | 32,833 | 163,154 | 165 K to 163.2 K (-1.10 %) |
Aug 19 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 18.15 | 12,551 | 227,801 | 282,775 | 295.3 K to 282.8 K (-4.25 %) |
Aug 19 2019 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 18.15 | 3,819 | 69,315 | 162,759 | 166.6 K to 162.8 K (-2.29 %) |
Aug 19 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 18.15 | 5,063 | 91,893 | 122,872 | 127.9 K to 122.9 K (-3.96 %) |
Aug 19 2019 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Sell | S | 18.15 | 3,245 | 58,897 | 92,668 | 95.9 K to 92.7 K (-3.38 %) |
Aug 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 7.21 | 25,000 | 180,250 | 0 | |
Aug 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 17.79 | 25,000 | 444,750 | 127,935 | 152.9 K to 127.9 K (-16.35 %) |
Aug 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 7.21 | 25,000 | 180,250 | 152,935 | 127.9 K to 152.9 K (+19.54 %) |
Jul 25 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 7.21 | 33,333 | 240,331 | 100,000 | |
Jul 25 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 7.21 | 33,334 | 240,338 | 132,333 | |
Jul 25 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 7.21 | 33,333 | 240,331 | 166,667 | |
Jul 25 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 29.65 | 33,333 | 988,323 | 295,326 | 328.7 K to 295.3 K (-10.14 %) |
Jul 25 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 7.21 | 33,333 | 240,331 | 328,659 | 295.3 K to 328.7 K (+11.29 %) |
Jul 25 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 32.11 | 33,334 | 1,070,355 | 295,326 | 328.7 K to 295.3 K (-10.14 %) |
Jul 25 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 7.21 | 33,334 | 240,338 | 328,660 | 295.3 K to 328.7 K (+11.29 %) |
Jul 25 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 32.10 | 33,333 | 1,069,989 | 295,326 | 328.7 K to 295.3 K (-10.14 %) |
Jul 25 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 7.21 | 33,333 | 240,331 | 328,659 | 295.3 K to 328.7 K (+11.29 %) |
Jul 12 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 7.21 | 25,000 | 180,250 | 25,000 | |
Jul 12 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 34.57 | 25,000 | 864,250 | 127,935 | 152.9 K to 127.9 K (-16.35 %) |
Jul 12 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 7.21 | 25,000 | 180,250 | 152,935 | 127.9 K to 152.9 K (+19.54 %) |
Jul 10 2019 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Option Exercise | M | 9.24 | 10,000 | 92,400 | 0 | |
Jul 10 2019 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Sell | S | 34.63 | 10,000 | 346,300 | 23,200 | 33.2 K to 23.2 K (-30.12 %) |
Jul 10 2019 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Buy | M | 9.24 | 10,000 | 92,400 | 33,200 | 23.2 K to 33.2 K (+43.10 %) |
Jun 19 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 7.21 | 25,000 | 180,250 | 50,000 | |
Jun 19 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 33.71 | 25,000 | 842,750 | 127,935 | 152.9 K to 127.9 K (-16.35 %) |
Jun 19 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 7.21 | 25,000 | 180,250 | 152,935 | 127.9 K to 152.9 K (+19.54 %) |
May 23 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 7.21 | 33,333 | 240,331 | 0 | |
May 23 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 7.21 | 33,334 | 240,338 | 33,333 | |
May 23 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 7.21 | 33,333 | 240,331 | 66,667 | |
May 23 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 32.69 | 33,333 | 1,089,656 | 295,326 | 328.7 K to 295.3 K (-10.14 %) |
May 23 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 7.21 | 33,333 | 240,331 | 328,659 | 295.3 K to 328.7 K (+11.29 %) |
May 23 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 33.38 | 33,334 | 1,112,689 | 295,326 | 328.7 K to 295.3 K (-10.14 %) |
May 23 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 7.21 | 33,334 | 240,338 | 328,660 | 295.3 K to 328.7 K (+11.29 %) |
May 23 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 32.93 | 33,333 | 1,097,656 | 295,326 | 328.7 K to 295.3 K (-10.14 %) |
May 23 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 7.21 | 33,333 | 240,331 | 328,659 | 295.3 K to 328.7 K (+11.29 %) |
May 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 31.37 | 1,928 | 60,481 | 164,463 | 166.4 K to 164.5 K (-1.16 %) |
May 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 31.37 | 13,383 | 419,825 | 295,326 | 308.7 K to 295.3 K (-4.34 %) |
May 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 31.37 | 4,077 | 127,895 | 166,578 | 170.7 K to 166.6 K (-2.39 %) |
May 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 31.37 | 3,767 | 118,171 | 127,935 | 131.7 K to 127.9 K (-2.86 %) |
May 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Sell | S | 31.37 | 2,449 | 76,825 | 94,694 | 97.1 K to 94.7 K (-2.52 %) |
May 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Sell | S | 31.37 | 3,461 | 108,572 | 95,913 | 99.4 K to 95.9 K (-3.48 %) |
Mar 12 2019 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | M | 5.14 | 10,000 | 51,400 | 0 | |
Mar 12 2019 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Buy | M | 5.14 | 10,000 | 51,400 | 145,083 | 135.1 K to 145.1 K (+7.40 %) |
Feb 21 2019 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 42.39 | 1,808 | 76,641 | 166,391 | 168.2 K to 166.4 K (-1.07 %) |
Feb 21 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 7.21 | 33,333 | 240,331 | 100,000 | |
Feb 21 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 7.21 | 33,334 | 240,338 | 133,333 | |
Feb 21 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 7.21 | 33,333 | 240,331 | 166,667 | |
Feb 21 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 41.01 | 33,333 | 1,366,986 | 308,709 | 342 K to 308.7 K (-9.75 %) |
Feb 21 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 7.21 | 33,333 | 240,331 | 342,042 | 308.7 K to 342 K (+10.80 %) |
Feb 21 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 43.20 | 33,334 | 1,440,029 | 308,709 | 342 K to 308.7 K (-9.75 %) |
Feb 21 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 7.21 | 33,334 | 240,338 | 342,043 | 308.7 K to 342 K (+10.80 %) |
Feb 21 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 42.39 | 8,882 | 376,508 | 308,709 | 317.6 K to 308.7 K (-2.80 %) |
Feb 21 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 42.32 | 33,333 | 1,410,653 | 317,591 | 350.9 K to 317.6 K (-9.50 %) |
Feb 21 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 7.21 | 33,333 | 240,331 | 350,924 | 317.6 K to 350.9 K (+10.50 %) |
Feb 21 2019 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 42.39 | 3,822 | 162,015 | 170,655 | 174.5 K to 170.7 K (-2.19 %) |
Feb 21 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 42.39 | 3,592 | 152,265 | 131,702 | 135.3 K to 131.7 K (-2.65 %) |
Feb 21 2019 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Sell | S | 42.39 | 2,386 | 101,143 | 97,143 | 99.5 K to 97.1 K (-2.40 %) |
Feb 21 2019 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Sell | S | 42.39 | 3,310 | 140,311 | 99,374 | 102.7 K to 99.4 K (-3.22 %) |
Feb 06 2019 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 10.69 | 16,119 | 172,312 | 0 | |
Feb 06 2019 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 42.16 | 16,119 | 679,577 | 168,199 | 184.3 K to 168.2 K (-8.75 %) |
Feb 06 2019 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 10.69 | 16,119 | 172,312 | 184,318 | 168.2 K to 184.3 K (+9.58 %) |
Jan 30 2019 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | M | 10.69 | 63,000 | 673,470 | 0 | |
Jan 30 2019 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 42.82 | 63,000 | 2,697,660 | 174,477 | 237.5 K to 174.5 K (-26.53 %) |
Jan 30 2019 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Buy | M | 10.69 | 63,000 | 673,470 | 237,477 | 174.5 K to 237.5 K (+36.11 %) |
Dec 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 36.51 | 22,150 | 808,697 | 22,150 | |
Dec 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Grant | A | 0.00 | 10,950 | 0 | 168,199 | 157.2 K to 168.2 K (+6.96 %) |
Dec 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | A | 36.51 | 138,350 | 5,051,159 | 138,350 | |
Dec 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Grant | A | 0.00 | 68,450 | 0 | 317,591 | 249.1 K to 317.6 K (+27.47 %) |
Dec 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | A | 36.51 | 58,100 | 2,121,231 | 58,100 | |
Dec 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Grant | A | 0.00 | 28,750 | 0 | 135,294 | 106.5 K to 135.3 K (+26.98 %) |
Dec 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Option Exercise | A | 36.51 | 37,350 | 1,363,649 | 37,350 | |
Dec 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Grant | A | 0.00 | 18,500 | 0 | 99,529 | 81 K to 99.5 K (+22.83 %) |
Dec 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Option Exercise | A | 36.51 | 48,400 | 1,767,084 | 48,400 | |
Dec 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Grant | A | 0.00 | 23,950 | 0 | 102,684 | 78.7 K to 102.7 K (+30.42 %) |
Nov 19 2018 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 38.25 | 4,016 | 153,612 | 157,249 | 161.3 K to 157.2 K (-2.49 %) |
Nov 19 2018 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 38.25 | 15,326 | 586,220 | 249,141 | 264.5 K to 249.1 K (-5.80 %) |
Nov 19 2018 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 38.25 | 5,982 | 228,812 | 174,477 | 180.5 K to 174.5 K (-3.31 %) |
Nov 19 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 38.25 | 6,515 | 249,199 | 106,544 | 113.1 K to 106.5 K (-5.76 %) |
Nov 19 2018 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Sell | S | 38.25 | 4,694 | 179,546 | 81,029 | 85.7 K to 81 K (-5.48 %) |
Nov 19 2018 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Sell | S | 38.25 | 4,524 | 173,043 | 78,734 | 83.3 K to 78.7 K (-5.43 %) |
Nov 05 2018 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Grant | A | 0.00 | 90,000 | 0 | 161,265 | 71.3 K to 161.3 K (+126.29 %) |
Oct 01 2018 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 60.91 | 9,500 | 578,645 | 9,500 | |
Oct 01 2018 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Grant | A | 0.00 | 4,750 | 0 | 181,750 | 177 K to 181.8 K (+2.68 %) |
Oct 01 2018 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Option Exercise | A | 60.91 | 9,500 | 578,645 | 9,500 | |
Oct 01 2018 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Grant | A | 0.00 | 4,750 | 0 | 23,200 | 18.5 K to 23.2 K (+25.75 %) |
Oct 01 2018 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Option Exercise | A | 60.91 | 9,500 | 578,645 | 9,500 | |
Oct 01 2018 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Grant | A | 0.00 | 4,750 | 0 | 45,250 | 40.5 K to 45.3 K (+11.73 %) |
Oct 01 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | A | 60.91 | 9,500 | 578,645 | 9,500 | |
Oct 01 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Grant | A | 0.00 | 4,750 | 0 | 135,083 | 130.3 K to 135.1 K (+3.64 %) |
Oct 01 2018 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | A | 60.91 | 9,500 | 578,645 | 9,500 | |
Oct 01 2018 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Grant | A | 0.00 | 4,750 | 0 | 274,473 | 269.7 K to 274.5 K (+1.76 %) |
Oct 01 2018 | NKTR | NEKTAR THERAPEUTIC ... | Ajer Jeffrey Robert | Director | Option Exercise | A | 60.91 | 9,500 | 578,645 | 9,500 | |
Oct 01 2018 | NKTR | NEKTAR THERAPEUTIC ... | Ajer Jeffrey Robert | Director | Grant | A | 0.00 | 4,750 | 0 | 20,500 | 15.8 K to 20.5 K (+30.16 %) |
Oct 01 2018 | NKTR | NEKTAR THERAPEUTIC ... | EASTHAM KARIN | Director | Option Exercise | A | 60.91 | 17,000 | 1,035,470 | 17,000 | |
Oct 01 2018 | NKTR | NEKTAR THERAPEUTIC ... | EASTHAM KARIN | Director | Grant | A | 0.00 | 8,500 | 0 | 8,500 | 0 to 8.5 K |
Sep 21 2018 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Sell | S | 56.98 | 9,000 | 512,820 | 18,450 | 27.5 K to 18.5 K (-32.79 %) |
Sep 21 2018 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Sell | S | 56.81 | 4,500 | 255,645 | 269,723 | 274.2 K to 269.7 K (-1.64 %) |
Sep 21 2018 | NKTR | NEKTAR THERAPEUTIC ... | Ajer Jeffrey Robert | Director | Sell | S | 56.76 | 6,750 | 383,130 | 15,750 | 22.5 K to 15.8 K (-30.00 %) |
Sep 06 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | M | 5.14 | 10,000 | 51,400 | 10,000 | |
Sep 06 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Sell | S | 67.39 | 10,000 | 673,900 | 130,333 | 140.3 K to 130.3 K (-7.13 %) |
Sep 06 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Buy | M | 5.14 | 10,000 | 51,400 | 140,333 | 130.3 K to 140.3 K (+7.67 %) |
Aug 21 2018 | NKTR | NEKTAR THERAPEUTIC ... | WINGER DENNIS L | Director | Option Exercise | M | 14.26 | 15,000 | 213,900 | 0 | |
Aug 21 2018 | NKTR | NEKTAR THERAPEUTIC ... | WINGER DENNIS L | Director | Option Exercise | M | 14.26 | 15,000 | 213,900 | 15,000 | |
Aug 21 2018 | NKTR | NEKTAR THERAPEUTIC ... | WINGER DENNIS L | Director | Sell | S | 60.30 | 15,000 | 904,500 | 42,750 | 57.8 K to 42.8 K (-25.97 %) |
Aug 21 2018 | NKTR | NEKTAR THERAPEUTIC ... | WINGER DENNIS L | Director | Buy | M | 14.26 | 15,000 | 213,900 | 57,750 | 42.8 K to 57.8 K (+35.09 %) |